Cozad Asset Management’s Novartis NVS Stock Holding History

Cozad Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$300K	Sell	1,967 -231	-11%	-$35.4K	0.02%	361
2025 Q4	$303K	Hold	2,198	–	–	0.02%	352
2025 Q3	$282K	Buy	2,198 +40	+2%	+$4.88K	0.02%	366
2025 Q2	$261K	Hold	2,158	–	–	0.02%	364
2025 Q1	$241K	Hold	2,158	–	–	0.02%	355
2024 Q4	$210K	Sell	2,158 -106	-5%	-$11.3K	0.02%	381
2024 Q3	$260K	Sell	2,264 -50	-2%	-$5.67K	0.02%	353
2024 Q2	$246K	Hold	2,314	–	–	0.02%	348
2024 Q1	$224K	Sell	2,314 -104	-4%	-$10.7K	0.02%	365
2023 Q4	$244K	Hold	2,418	–	–	0.03%	345
2023 Q3	$246K	Sell	2,418 -335	-12%	-$34K	0.03%	324
2023 Q2	$278K	Hold	2,753	–	–	0.03%	319
2023 Q1	$253K	Sell	2,753 -1,025	-27%	-$89.5K	0.03%	331
2022 Q4	$343K	Hold	3,778	–	–	0.05%	279
2022 Q3	$287K	Buy	3,778 +280	+8%	+$23.2K	0.05%	283
2022 Q2	$296K	Hold	3,498	–	–	0.05%	283
2022 Q1	$307K	Buy	3,498 +300	+9%	+$26K	0.04%	288
2021 Q4	$280K	Sell	3,198 -165	-5%	-$13.7K	0.04%	291
2021 Q3	$275K	Hold	3,363	–	–	0.04%	284
2021 Q2	$307K	Sell	3,363 -998	-23%	-$88.9K	0.05%	270
2021 Q1	$373K	Buy	4,361 +150	+4%	+$13.5K	0.06%	247
2020 Q4	$398K	Sell	4,211 -48	-1%	-$4.19K	0.07%	222
2020 Q3	$370K	Sell	4,259 -131	-3%	-$11.3K	0.07%	228
2020 Q2	$383K	Sell	4,390 -439	-9%	-$37.9K	0.08%	219
2020 Q1	$398K	Sell	4,829 -135	-3%	-$12K	0.14%	144
2019 Q4	$470K	Sell	4,964 -383	-7%	-$34.4K	0.13%	150
2019 Q3	$465K	Hold	5,347	–	–	0.13%	151
2019 Q2	$488K	Sell	5,347 -804	-13%	-$68K	0.14%	145
2019 Q1	$530K	Hold	6,151	–	–	0.16%	137
2018 Q4	$473K	Buy	6,151 +111	+2%	+$8.64K	0.16%	137
2018 Q3	$466K	Sell	6,040 -134	-2%	-$9.91K	0.14%	141
2018 Q2	$418K	Buy	+6,174	New	+$426K	0.13%	147

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cozad Asset Management's NVS Position: Q1 2026 in Review

Cozad Asset Management reduced its Novartis (NVS) stake by 11% in Q1 2026, selling an estimated $35.4K and leaving 1,967 shares worth $300K. The position accounts for 0.02% of the portfolio, ranked #361.

Cozad Asset Management first reported a position in NVS in Q2 2018 and has held it in 32 quarters since. The position peaked at $530K in Q1 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Cozad Asset Management held 1,967 shares of Novartis worth $300K as of Q1 2026.
Cozad Asset Management sold 231 Novartis shares in Q1 2026, an estimated $35.4K.
Novartis made up 0.02% of Cozad Asset Management's portfolio in Q1 2026, its #361 holding.
Cozad Asset Management first reported a position in Novartis in Q2 2018 and has held it in 32 quarters since.
Cozad Asset Management's Novartis position peaked at $530K in Q1 2019.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.